FRRB funds the Glastonbury Group to study the immune landscape of pancreatic cancer
The Glastonbury Group at Human Technopole has been awarded a competitive grant as part of the “From Bed To Bench: the way to innovation” funding programme promoted by the Fondazione Regionale per la Ricerca Biomedica (FRRB). The study, funded with 2.000.000 euros, 600.000 of which will go to the Glastonbury group directly, will begin in late 2025 and run for 3 years.
HT National Facilities: Upcoming Call for Access 2025 – Round 2
On 27 and 28 March, the SIEC (Standing Independent Evaluation Committee), visited HT to discuss the results of the first call for access, which was considered a pilot phase, and refine the upcoming call, planned to be published at the beginning of June 2025.
Advancing Precision Immunotherapy for Paediatric Leukaemia with Alice Giustacchini and her Group
Meet Alice Giustacchini, Research Group Leader in Population and Medical Genomics. Her project, titled “Tailoring Precision Immunotherapy to Paediatric Acute Myeloid Leukaemia,” aims to study the cellular and molecular dynamics of CAR-T cell therapy in blood cancers.
Human Technopole’s National Facilities: new Call for Access now Open
The new call for Access to the National Facilities services is now open! The Human Technopole’s National Facilities continue to expand their support for cutting-edge research by launching the first Call for Access of 2025. Building on the success of the 24-PILOT call, to which over 120 projects have applied, this new opportunity allows researchers to benefit from state-of-the-art technologies and expertise.
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.
Previous page